Effect of ionic crosslinking on the drug release properties of chitosan diacetate matrices

被引:23
作者
Aiedeh, Khaled M. [1 ]
Taha, Mutasem O. [1 ]
Al-Hiari, Yusuf [1 ]
Bustanji, Yasser [1 ]
Alkhatib, Hatim S. [1 ]
机构
[1] Univ Jordan, Fac Pharm, Amman 11942, Jordan
关键词
controlled delivery; complexation; oral drug delivery; polymer synthesis; polymeric drug delivery systems; chitosan diacetate; ionotropic crosslinking; Al3+; Zn2+; Ca2+; electrophilic softness/hardness scale;
D O I
10.1002/jps.20764
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Chitosan diacetate (CDA) was prepared by alkylating the amino moieties of chitosan with mono-iodoacetic acid. Subsequently, CDA was cross-linked with Al3+, Zn2+, and Ca2+ ions to yield three ionotropically crosslinked polymeric matrices. These composite matrices were characterized employing infrared spectroscopy (IR) and differential scanning calorimetry (DSC). Subsequently, they were loaded with caffeine, as a model drug, and were assessed as sustained release carriers by evaluating their caffeine release profiles. Interestingly, only CDA-Zn2+ complex sustained the release of caffeine effectively in a zero-order manner. The drug release and thermal behavior of the tested matrices agree with the relative strength of the ionic or coordination character of the bonds. This, in turn, depends on the position of the complexing ions on the electrophilic softness/hardness scale. (c) 2006 Wiley-Liss, Inc.
引用
收藏
页码:38 / 43
页数:6
相关论文
共 14 条
[1]   Synthesis of iron-crosslinked chitosan succinate and iron-crosslinked hydroxamated chitosan succinate and their in vitro evaluation as potential matrix materials for oral theophylline sustained-release beads [J].
Aiedeh, K ;
Taha, MO .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2001, 13 (02) :159-168
[2]  
ALKHATIB HS, IN PRESS EUR POLYM J
[3]   Structure and interactions in chitosan hydrogels formed by complexation or aggregation for biomedical applications [J].
Berger, J ;
Reist, M ;
Mayer, JM ;
Felt, O ;
Gurny, R .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2004, 57 (01) :35-52
[4]  
Fleming I, 1996, FRONTIER ORBITALS OR, P1
[5]   Mitoxantrone-loaded BSA nanospheres and chitosan nanospheres for local injection against breast cancer and its lymph node metastases - II: Tissue distribution and pharmacodynamics [J].
Lu, B ;
Xiong, SB ;
Yang, H ;
Yin, XD ;
Zhao, RB .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2006, 307 (02) :175-181
[6]   Investigation of novel alginate-magnesium aluminum silicate microcomposite films for modified-release tablets [J].
Pongjanyakul, T ;
Priprem, A ;
Puttipipatkhachorn, S .
JOURNAL OF CONTROLLED RELEASE, 2005, 107 (02) :343-356
[7]  
Pourmorad F., 2005, International Journal of Biology and Biotechnology, V2, P429
[8]   Chitosan-based particles as controlled drug delivery systems [J].
Prabaharan, M ;
Mano, JF .
DRUG DELIVERY, 2005, 12 (01) :41-57
[9]  
Prego Cecilia, 2005, Expert Opin Drug Deliv, V2, P843, DOI 10.1517/17425247.2.5.843
[10]   THE ABNORMAL FINKELSTEIN REACTION - A SEQUENTIAL IONIC-FREE RADICAL REACTION-MECHANISM [J].
SMITH, WB ;
BRANUM, GD .
TETRAHEDRON LETTERS, 1981, 22 (22) :2055-2058